Objective To investigate the damage of stopping Adefovir without doctor's advice.Methods Clinical manifestations,prognosis of 47 cases with hepatitis B stop Adefovir without doctor's advice were analyzed retrospectively.Results Among the cases stopping adefovir without doctor's advice to take a change for the worse,8 cases HBVDNA positive within a month,34 cases in 3 months,41 cases in 6 months.And 4 patients with liver cirrhosis died,33 cases took Adefovir again,10 cases took entecavir,and gradually got well.Conclusion Stopping Adefovir dipivoxil without doctor's advice may be lead to elevated HBVDNA,change for the worse.

Objective To explore the influence of partial splenic embolization (PSE) on the factors related to alimentary canal bleeding in hepatocirrhosis. Methods Forty-nine cases of hepatocirrhosis patient with alimentary canal bleeding were selected according to the sequence of entrance. In these patients, 28 cases were set in treatment group and the rest 21 cases were control group. Besides basic therapeutic measures PSE technique were given to the patients of treatment group, while the patients in control group received basic therapeutic measures only. And the blood routine test, prothrombin time(PT), liver function tests, B type ultrasonography and gastroscopy were conducted or observed respectively before operation and 7 days, 1 month, 6 months, 1 year after operation. Results ① days after operation, the count of blood platelets and white blood cells in peripheral blood of therapy group were higher obviously than those of control group (P

Objective To determine the clinical effects of type Ⅲ biliary atresia treated by hepatojejunostomy (Kasai procedure).Methods A retrospective study was performed on patients with type Ⅲ biliary atresia treated in our hospital between January 2009 to December 2013.Results The follow-up data were completed in 42 patients out of 48 patients (87.5％) who underwent Kasai procedure for type Ⅲ biliary atresia.The jaundice disappeared in 31 of 42 patients (73.8％).The rate of patients having cholangitis was 47.6％.There were significant differences in the 2-year survival among the groups of patients with mild cholangitis (75.0％,9/12),serious cholangitis (25.0％,2/8) and without cholangitis (86.4％,19/22) (P ＜ 0.05).Conclusions Hepatojejunostomy (Kasai procedure) is an effective operation to treat type Ⅲ biliary atresia.Our data suggested that the survival rates were related to the degree of bile drainage and cholangitis post surgery.